RFC1 and colorectal carcinoma: It was difficult to collect sufficient CRC patient samples and to carry out the in vitro and in vivo studies or find a suitable public database to evaluate the clinical significance of miR-26a-5p or targeted RFC1 and miR-636 targeted RFC5 in terms of expression levels and CRC progression.